Clinical Trials
312 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
DAREONâ„¢-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
Boehringer Ingelheim
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
National Institutes of Health Clinical Center (CC)
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
National Institutes of Health Clinical Center (CC)
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
National Cancer Institute (NCI)
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
National Institutes of Health Clinical Center (CC)
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
National Institutes of Health Clinical Center (CC)
Evaluation and Treatment of Neurosurgical Disorders
National Institutes of Health Clinical Center (CC)
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
National Institutes of Health Clinical Center (CC)
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery
National Institutes of Health Clinical Center (CC)
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
National Institutes of Health Clinical Center (CC)
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Fox Chase Cancer Center
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Case Comprehensive Cancer Center
PRO-NEM1
Centre Hospitalier Universitaire Dijon
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
National Cancer Institute (NCI)
XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Northwestern University
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
SystImmune Inc.
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
Daiichi Sankyo
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Molecular Partners AG
INDIGO
Boston Scientific Corporation
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Barts & The London NHS Trust
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
National Institutes of Health Clinical Center (CC)
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
Jiangsu HengRui Medicine Co., Ltd.
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
National Institutes of Health Clinical Center (CC)
PTC-RFA
University Health Network, Toronto
Tumor HI
Rezolute
The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support
M.D. Anderson Cancer Center
NET-TIME
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
University of Wisconsin, Madison
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Perspective Therapeutics
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
National Cancer Institute (NCI)
ELEGANCE
Nantes University Hospital
EUSRFAINSU
Sahlgrenska University Hospital
Studies on Tumors of the Thyroid
National Institutes of Health Clinical Center (CC)
Diagnosing and Treating Low Blood Sugar Levels
National Institutes of Health Clinical Center (CC)
Natural History of Familial Carcinoid Tumor
National Institutes of Health Clinical Center (CC)
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
National Institutes of Health Clinical Center (CC)
Natural History Study of Parathyroid Disorders
National Institutes of Health Clinical Center (CC)
LEVEL
Grupo Espanol de Tumores Neuroendocrinos
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
National Institutes of Health Clinical Center (CC)
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
University of Alberta
MK-6482-015
Merck Sharp & Dohme LLC
BRAVESST2
Crinetics Pharmaceuticals Inc.
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
Haukeland University Hospital
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
Arizona State University
Diagnosis of Pheochromocytoma
National Institutes of Health Clinical Center (CC)
German Adrenocortical Carcinoma Registry
University of Wuerzburg
Adrenal Tumors - Pathogenesis and Therapy
University of Wuerzburg
Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
Shanghai 6th People's Hospital